Brackeen M - Search Results

1

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.

Wiley JL, Marusich JA, Blough BE, Namjoshi O, Brackeen M, Akinfiresoye LR, Walker TD, Prioleau C, Barrus DG, Gamage TF. Wiley JL, et al. Among authors: brackeen m. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jun 8;132:110984. doi: 10.1016/j.pnpbp.2024.110984. Epub 2024 Feb 27. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 38417478

2

Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist.

Decker AM, Brackeen MF, Mohammadkhani A, Kormos CM, Hesk D, Borgland SL, Blough BE. Decker AM, et al. Among authors: brackeen mf. ACS Chem Neurosci. 2022 Apr 6;13(7):1082-1095. doi: 10.1021/acschemneuro.2c00086. Epub 2022 Mar 24. ACS Chem Neurosci. 2022. PMID: 35325532 Free PMC article.

3

Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.

Zhang Y, Burgess JP, Brackeen M, Gilliam A, Mascarella SW, Page K, Seltzman HH, Thomas BF. Zhang Y, et al. Among authors: brackeen m. J Med Chem. 2008 Jun 26;51(12):3526-39. doi: 10.1021/jm8000778. J Med Chem. 2008. PMID: 18512901

4

Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs.

Thomas BF, Zhang Y, Brackeen M, Page KM, Mascarella SW, Seltzman HH. Thomas BF, et al. Among authors: brackeen m. AAPS J. 2006 Oct 27;8(4):E665-71. doi: 10.1208/aapsj080476. AAPS J. 2006. PMID: 17233530 Free PMC article.

5

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW Jr, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA Jr, Noble SA, Oliver W Jr, Parks DJ, Plunket KD, Szewczyk JR, Willson TM. Henke BR, et al. Among authors: brackeen mf. J Med Chem. 1998 Dec 3;41(25):5020-36. doi: 10.1021/jm9804127. J Med Chem. 1998. PMID: 9836620

6

Introduction of a conformational switching element on a pyrrolidine ring. Synthesis and evaluation of (R*,R*)-(+/-)-methyl 3-acetyl-4-[3- (cyclopentyloxy)-4-methoxyphenyl]-3-methyl-1-pyrrolidinecarboxylate, a potent and selective inhibitor of cAMP-specific phosphodiesterase.

Stafford JA, Veal JM, Feldman PL, Valvano NL, Baer PG, Brackeen MF, Brawley ES, Connolly KM, Domanico PL, Han B, et al. Stafford JA, et al. Among authors: brackeen mf. J Med Chem. 1995 Dec 22;38(26):4972-5. doi: 10.1021/jm00026a003. J Med Chem. 1995. PMID: 8544172 No abstract available.

7

Design and synthesis of conformationally constrained analogues of 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) as potent inhibitors of cAMP-specific phosphodiesterase.

Brackeen MF, Cowan DJ, Stafford JA, Schoenen FJ, Veal JM, Domanico PL, Rose D, Strickland AB, Verghese M, Feldman PL. Brackeen MF, et al. J Med Chem. 1995 Nov 24;38(24):4848-54. doi: 10.1021/jm00024a012. J Med Chem. 1995. PMID: 7490734

8

Phosphodiesterase type IV inhibition. Structure-activity relationships of 1,3-disubstituted pyrrolidines.

Feldman PL, Brackeen MF, Cowan DJ, Marron BE, Schoenen FJ, Stafford JA, Suh EM, Domanico PL, Rose D, Leesnitzer MA, et al. Feldman PL, et al. Among authors: brackeen mf. J Med Chem. 1995 Apr 28;38(9):1505-10. doi: 10.1021/jm00009a011. J Med Chem. 1995. PMID: 7739009

9

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.

Sekut L, Yarnall D, Stimpson SA, Noel LS, Bateman-Fite R, Clark RL, Brackeen MF, Menius JA Jr, Connolly KM. Sekut L, et al. Among authors: brackeen mf. Clin Exp Immunol. 1995 Apr;100(1):126-32. doi: 10.1111/j.1365-2249.1995.tb03613.x. Clin Exp Immunol. 1995. PMID: 7697910 Free PMC article.

10

Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation.

Sekut L, Menius JA Jr, Brackeen MF, Connolly KM. Sekut L, et al. Among authors: brackeen mf. J Lab Clin Med. 1994 Dec;124(6):813-20. J Lab Clin Med. 1994. PMID: 7798795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page